Abbott is again tapping into the competitive spirit of Big Ten universities to drive blood donations,
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and…
Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
With all the fretting from the pharmaceutical industry about competition from China, patent protection losses, price reduction…
This week on "The Top Line," we’re covering some of the biggest stories across biopharma before turning to one of the industry’s…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
